Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection

MLA

Travis E. Grotz, et al. “Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.” Annals of Surgical Oncology, vol. 24, no. 9, Apr. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e35139a44f58d0f569297c090fd8fc2a&authtype=sso&custid=ns315887.

APA

Travis E. Grotz, Melissa W. Taggart, Aurelio Matamoros, Gary N. Mann, Richard E. Royal, Safia Rafeeq, Paul F. Mansfield, Kanwal Pratap Singh Raghav, Michael J. Overman, Karen A. Beaty, Kristen A. Robinson, Cathy Eng, & Keith Fournier. (2017). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection. Annals of Surgical Oncology, 24(9).

Chicago

Travis E. Grotz, Melissa W. Taggart, Aurelio Matamoros, Gary N. Mann, Richard E. Royal, Safia Rafeeq, Paul F. Mansfield, et al. 2017. “Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.” Annals of Surgical Oncology 24 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e35139a44f58d0f569297c090fd8fc2a&authtype=sso&custid=ns315887.